Amundi increased its stake in Integer Holdings Co. (NYSE:ITGR - Free Report) by 194.3% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 17,372 shares of the medical equipment provider's stock after buying an additional 11,469 shares during the quarter. Amundi owned about 0.05% of Integer worth $2,313,000 as of its most recent filing with the SEC.
Several other hedge funds have also modified their holdings of the stock. Loomis Sayles & Co. L P grew its position in Integer by 3.0% in the third quarter. Loomis Sayles & Co. L P now owns 538,027 shares of the medical equipment provider's stock valued at $69,943,000 after acquiring an additional 15,446 shares in the last quarter. Jane Street Group LLC grew its holdings in Integer by 23.3% during the 3rd quarter. Jane Street Group LLC now owns 151,397 shares of the medical equipment provider's stock valued at $19,682,000 after purchasing an additional 28,572 shares in the last quarter. Verition Fund Management LLC increased its stake in Integer by 17.4% during the 3rd quarter. Verition Fund Management LLC now owns 3,470 shares of the medical equipment provider's stock worth $451,000 after buying an additional 515 shares during the period. Versant Capital Management Inc boosted its position in Integer by 98.4% in the 4th quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider's stock valued at $49,000 after buying an additional 183 shares during the last quarter. Finally, KBC Group NV grew its stake in shares of Integer by 83.3% during the fourth quarter. KBC Group NV now owns 1,598 shares of the medical equipment provider's stock valued at $212,000 after acquiring an additional 726 shares in the last quarter. 99.29% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Several research firms recently commented on ITGR. Citigroup boosted their price target on Integer from $130.00 to $145.00 and gave the stock a "neutral" rating in a research note on Wednesday, December 11th. Oppenheimer cut Integer from an "outperform" rating to a "market perform" rating in a research note on Friday, February 21st. KeyCorp lifted their price target on shares of Integer from $144.00 to $154.00 and gave the stock an "overweight" rating in a research note on Friday, January 24th. Wells Fargo & Company reiterated an "overweight" rating and set a $160.00 price objective on shares of Integer in a research note on Tuesday, December 3rd. Finally, Truist Financial boosted their target price on shares of Integer from $147.00 to $163.00 and gave the stock a "buy" rating in a research report on Wednesday, December 11th. Two investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, Integer has an average rating of "Moderate Buy" and a consensus target price of $149.00.
Read Our Latest Report on ITGR
Integer Stock Performance
Shares of Integer stock traded down $4.56 on Thursday, reaching $116.12. 719,631 shares of the company were exchanged, compared to its average volume of 310,246. The firm has a market cap of $3.90 billion, a price-to-earnings ratio of 34.56, a P/E/G ratio of 1.72 and a beta of 1.24. The company's 50-day moving average is $133.30 and its two-hundred day moving average is $132.53. The company has a debt-to-equity ratio of 0.62, a quick ratio of 2.09 and a current ratio of 2.95. Integer Holdings Co. has a 1-year low of $107.11 and a 1-year high of $146.36.
Integer (NYSE:ITGR - Get Free Report) last announced its quarterly earnings results on Thursday, February 20th. The medical equipment provider reported $1.43 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.46 by ($0.03). The firm had revenue of $449.50 million for the quarter, compared to analyst estimates of $446.28 million. Integer had a net margin of 6.92% and a return on equity of 11.65%. As a group, research analysts expect that Integer Holdings Co. will post 6.01 earnings per share for the current fiscal year.
Integer Profile
(
Free Report)
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.
Featured Stories
Before you consider Integer, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integer wasn't on the list.
While Integer currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
